Harmony Biosciences Holdings, Inc.
HRMY
$29.17
$0.180.62%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 201.27M | 186.04M | 172.81M | 154.62M | 168.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 201.27M | 186.04M | 172.81M | 154.62M | 168.41M |
| Cost of Revenue | 54.41M | 42.78M | 32.14M | 27.48M | 43.15M |
| Gross Profit | 146.86M | 143.26M | 140.67M | 127.13M | 125.26M |
| SG&A Expenses | 56.47M | 56.16M | 55.73M | 52.91M | 54.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 145.54M | 124.33M | 151.46M | 102.58M | 128.22M |
| Operating Income | 55.73M | 61.71M | 21.36M | 52.03M | 40.20M |
| Income Before Tax | 56.16M | 62.17M | 21.69M | 51.79M | 39.69M |
| Income Tax Expenses | 6.68M | 16.08M | 10.10M | 13.45M | 13.08M |
| Earnings from Continuing Operations | 49.48M | 46.09M | 11.59M | 38.33M | 26.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.48M | 46.09M | 11.59M | 38.33M | 26.61M |
| EBIT | 55.73M | 61.71M | 21.36M | 52.03M | 40.20M |
| EBITDA | 61.70M | 67.68M | 27.41M | 58.16M | 46.32M |
| EPS Basic | 0.87 | 0.81 | 0.20 | 0.68 | 0.46 |
| Normalized Basic EPS | 0.61 | 0.68 | 0.24 | 0.57 | 0.43 |
| EPS Diluted | 0.85 | 0.79 | 0.20 | 0.67 | 0.45 |
| Normalized Diluted EPS | 0.60 | 0.67 | 0.24 | 0.56 | 0.42 |
| Average Basic Shares Outstanding | 57.10M | 56.87M | 56.80M | 56.77M | 58.32M |
| Average Diluted Shares Outstanding | 58.22M | 58.10M | 57.54M | 57.60M | 58.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
